Cargando…

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome

OBJECTIVE: Severe irritable bowel syndrome (IBS) in school children and adolescents often leads to stigmatisation, social withdrawal, disrupted education and psychological distress. While there are few effective treatment options for IBS in this age group, gut-focused hypnotherapy (GFH) has shown pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasant, Dipesh H, Hasan, Syed S, Cruickshanks, Pamela, Whorwell, Peter J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Neurogastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640435/ https://www.ncbi.nlm.nih.gov/pubmed/34917314 http://dx.doi.org/10.1136/flgastro-2020-101679

Ejemplares similares

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Six vs 12 Sessions of Gut-focused Hypnotherapy for Irritable Bowel Syndrome: A Randomized Trial
por: Hasan, Syed S., et al.
Publicado: (2021)

Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
por: Tooth, David, et al.
Publicado: (2014)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Rumination syndrome: pathophysiology, diagnosis and practical management
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions
por: Donnet, Anne-Sophie, et al.
Publicado: (2022)

Mo1423: PATIENT PERSPECTIVES ON REMOTE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME DURING THE COVID-19 PANDEMIC: THE 'NEW NORM’ OR JUST A TEMPORARY SOLUTION?
por: Noble, Hithin, et al.
Publicado: (2022)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
por: Rolland-Fourcade, Claire, et al.
Publicado: (2017)

Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol
por: Vasant, Dipesh H., et al.
Publicado: (2019)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2018)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
por: McPherson, Zachary E., et al.
Publicado: (2021)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
por: van Assen, Tijmen, et al.
Publicado: (2012)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
por: Akbar, A, et al.
Publicado: (2008)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
por: Seeling, Katharina Sophie, et al.
Publicado: (2023)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
por: McEvoy, Mark A., et al.
Publicado: (2021)

SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment
por: Hasan, Shariq S., et al.
Publicado: (2019)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
por: Everitt, Hazel Anne, et al.
Publicado: (2019)

Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome
por: Carruthers, Helen R, et al.
Publicado: (2010)

The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic
por: Noble, Hithin, et al.
Publicado: (2022)

Gut fermentation syndrome: A systematic review of case reports
por: Bayoumy, Ahmed B., et al.
Publicado: (2021)

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
por: Lam, Ching, et al.
Publicado: (2016)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
por: Eccles, Jessica Anne, et al.
Publicado: (2020)

Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy
por: Peter, Johannes, et al.
Publicado: (2018)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
por: Savarino, Edoardo, et al.
Publicado: (2022)

Apelin targets gut contraction to control glucose metabolism via the brain
por: Fournel, Audren, et al.
Publicado: (2017)

How to address work impairment in patients with disorders of the gut–brain interaction?
por: Keszthelyi, Daniel
Publicado: (2023)

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations
por: Tornkvist, Navkiran T., et al.
Publicado: (2022)

Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education
por: Simons, Julia, et al.
Publicado: (2022)

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
por: Flik, Carla E, et al.
Publicado: (2011)

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
por: Frändemark, Åsa, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?
por: Purssell, Huw, et al.
Publicado: (2021)

Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study
por: Bergman, David, et al.
Publicado: (2023)

microRNA overexpression in slow transit constipation leads to reduced Na(V)1.5 current and altered smooth muscle contractility
por: Mazzone, Amelia, et al.
Publicado: (2020)

European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice
por: Nyssen, Olga P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4edfs13olkuvo5tbi785hc21tb